The UCSF Industry Documents Library released another 519,000 new Juul Labs documents, bringing the total number of documents to 1,053,233. This is about one-quarter of the complete collection of more than 4 million documents. Check out the Juul documents here.
Category Archives: dual use
NOW OPEN ACCESS: E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
NEJM Evidence has graciously made our recent paper, “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes,” open access so that anyone can read and download it for free. As described in more detail in my blog post on the paper, it uses data from 107 population epidemiology studies of the association between e-cigaretteContinue reading “NOW OPEN ACCESS: E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
5 year longitudinal study finds e-cigs and cigs have similar risks for respiratory disease and COPD; dual use is worse
Beibei Song and colleagues’ new paper, Impact of electronic cigarette usage on the onset of respiratory symptoms and COPD among Chinese adults, finds that e-cigarettes and cigarettes pose similar risks for causing respiratory symptoms and chronic obstructive disease (COPD) in Chinese adults. Dual use is worse than using either product alone. This is a veryContinue reading “5 year longitudinal study finds e-cigs and cigs have similar risks for respiratory disease and COPD; dual use is worse”
British smokers understand risks of e-cig use better than a lot of British health officials and scientists
England remains the country in which the government and (most of the) health establishment continue to aggressively promote e-cigarettes as a better alternative to cigarettes. As a result, Sarah Jackson and her colleagues were concerned about the results of their latest survey of smokers’ attitudes towards e-cigarettes, reported in their paper Trends in Harm PerceptionsContinue reading “British smokers understand risks of e-cig use better than a lot of British health officials and scientists”
FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes
As of February 22, 2024, the FDA was continuing to embrace the idea that there is a “continuum of risk” with combusted tobacco as the riskiest and e-cigarettes being substantially less risky. As a result, FDA promotes e-cigarettes as a way for smokers to reduce risk. This view is based on the fact that e-cigarettesContinue reading “FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes”
E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote
In the lead up to the WHO Framework Convention on Tobacco Control Tenth Conference of the Parties that starts today, advocates for e-cigarettes and other “reduced harm” tobacco products have been busy again arguing that delegates should embrace these products. In reviewing some of this material, I have been struck by the fact that theirContinue reading “COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote”
Replacing 50% of cigs with ecigs or HTP had no lung benefit
E-cigarette advocates and tobacco harm reduction advocates, as well as the FDA, have long promoted a 50% reduction in cigarette smoking as a positive outcome when assessing the value of e-cigarettes (recent example). The FDA’s use of this benchmark is particularly surprising because in 2021 FDA scientists published a meta-analysis of the effects of smokers reducingContinue reading “Replacing 50% of cigs with ecigs or HTP had no lung benefit”
Stanton Glantz blog 